AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
72_CD
Form_NN
20-F_JJ
Information_NOMZ
2004_CD
Group_NN
Profit_NN
and_PHC
Loss_NN
Account_NN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
Before_IN
exceptional_JJ
Exceptional_JJ
2004_CD
items_NN
items_NN
Total_JJ
Notes_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
Group_NN
turnover_NN
21,426_CD
21,426_CD
Operating_GER
costs_NN
1_CD
16,971_CD
16,971_CD
Other_JJ
operating_GER
income_NN
1_CD
315_CD
315_CD
Group_NN
operating_GER
profit_NN
1_CD
4,770_CD
4,770_CD
Share_NN
of_PIN
operating_VBG
profits_NN
of_PIN
joint_JJ
venture_NN
2_CD
Profit_NN
on_PIN
sale_NN
of_PIN
interest_NN
in_PIN
joint_JJ
venture_NN
3_CD
219_CD
219_CD
Dividend_NN
income_NN
6_CD
6_CD
Profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
interest_NN
4,776_CD
219_CD
4,995_CD
Net_JJ
interest_NN
490_CD
90_CD
Profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
taxation_NOMZ
4,866_CD
219_CD
5,085_CD
Taxation_NOMZ
5_CD
1,321_CD
67_CD
1,254_CD
Profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
after_IN
taxation_NOMZ
3,545_CD
286_CD
3,831_CD
Attributable_JJ
to_PIN
minorities_NOMZ
18_CD
18_CD
Net_JJ
profit_NN
for_PIN
the_DT
financial_JJ
year_NN
3,527_CD
286_CD
3,813_CD
Dividends_NN
to_PIN
shareholders_NN
6_CD
1,555_CD
Profit_NN
retained_VBN [WZPAST]
for_PIN
the_DT
financial_JJ
year_NN
2,258_CD
Earnings_GER
per_PIN
$_$
0.25_CD
Ordinary_NN
Share_NN
before_IN
exceptional_JJ
items_NN
7_CD
$_$
2.11_CD
$_$
2.11_CD
Earnings_GER
per_PIN
$_$
0.25_CD
Ordinary_NN
Share_NN
basic_JJ
7_CD
$_$
2.11_CD
$_$
0.17_CD
$_$
2.28_CD
Earnings_GER
per_PIN
$_$
0.25_CD
Ordinary_NN
Share_NN
diluted_VBD
7_CD
$_$
2.11_CD
$_$
0.17_CD
$_$
2.28_CD
Weighted_VBN
average_JJ
number_NN
of_PIN
Ordinary_NN
Shares_NN
in_PIN
issue_NN
millions_NN
7_CD
1,673_CD
All_QUAN
activities_NOMZ
were_VBD [BEMA]
in_PIN
respect_NN
of_PIN
continuing_VBG
operations_NOMZ
._.
There_EX
were_VBD
no_SYNE
material_NN
differences_NN
between_PIN
reported_VBN [PUBV]
profits_NN
and_PHC
losses_NN
and_CC
historical_JJ
cost_NN
profits_NN
and_PHC
losses_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
taxation_NOMZ
._.
Group_NN
Statement_NOMZ
of_PIN
Total_NN
Recognised_NN
Gains_NN
and_PHC
Losses_NN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2004_CD
Notes_NN
$_$
m_CD [BEMA]
Net_JJ
profit_NN
for_PIN
the_DT
financial_JJ
year_NN
3,813_CD
Foreign_NN
exchange_NN
adjustments_NOMZ
on_PIN
consolidation_NOMZ
20_CD
713_CD
Tax_NN
on_PIN
foreign_JJ
exchange_NN
adjustments_NOMZ
on_PIN
consolidation_NOMZ
20_CD
379_CD
Translation_NOMZ
differences_NN
on_PIN
foreign_JJ
currency_NN
borrowings_GER
20_CD
Tax_NN
on_PIN
translation_NOMZ
differences_NN
on_PIN
foreign_JJ
currency_NN
borrowings_GER
20_CD
Total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
relating_VBG [WZPRES]
to_PIN
the_DT
financial_JJ
year_NN
4,905_CD
Tax_NN
on_PIN
foreign_JJ
exchange_NN
adjustments_NOMZ
on_PIN
consolidation_NOMZ
in_PIN
2004_CD
includes_VPRT
a_DT
credit_NN
of_PIN
$_$
357m_CD
in_PIN
respect_NN
of_PIN
foreign_JJ
exchange_NN
losses_NN
arising_VBG [WZPRES]
in_PIN
2000_CD
see_VPRT [PRIV]
Note_NN
5_CD
._.
